PD-1 targeted Immunotherapy as first-line therapy for advanced non-small-cell lung cancer patients
J Thorac Dis
.
2017 Apr;9(4):E384-E386.
doi: 10.21037/jtd.2017.03.118.
Authors
Arik Bernard Schulze
1
,
Lars Henning Schmidt
1
Affiliation
1
Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany.
PMID:
28523184
PMCID:
PMC5418249
DOI:
10.21037/jtd.2017.03.118
No abstract available
Publication types
Editorial
Comment